Aedifica, BE0003851681

Aedifica invests EUR 105 million in Ireland: what it means for Aedifica stock

Published on 10/20/2026 at 10:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Four Irish healthcare projects include one completed nursing home and two sites due in early 2028. Aedifica stock costs EUR 62.58 on October 20, 2026.

Irish investment and upcoming dates

  • Aedifica is investing EUR 105.00 million in four Irish healthcare projects on October 12, 2026.
  • Two care homes in Kilcoole and Crumlin are due for completion in early 2028.
  • Aedifica stock trades at EUR 62.58 at 10:42 a.m. CEST at Lang & Schwarz on October 20, 2026.
  • Aedifica's interim statement is scheduled for November 18, 2026.
Syensqo S.A. (BE0003851681) präsentiert Firmensitz als malerische Aquarell-Stadtansicht mit weichen Pastellfarben und feinen Konturen, Illustration mit AI erstellt.

Aedifica (ISIN BE0003851681) is investing EUR 105.00 million in four Irish healthcare projects, including a completed nursing home and developments due for completion in early 2028, according to MarketScreener on October 12, 2026. The scale of the pipeline gives the stock a concrete operating story ahead of the next company update.

EUR 105 million pipeline

Aedifica said its Irish program includes the Limerick Cancer Centre, which had entered its final construction phase by October 12, 2026. The company also completed the Ursuline Convent Nursing Home in Sligo earlier in 2026, adding capacity for 105 residents, while projects in Kilcoole and Crumlin were progressing through construction.

The Kilcoole care home is designed for 109 residents and the Crumlin site for 151 residents. The two projects are expected to reach completion around the start of 2028, while another building in the group is due to finish by the end of 2026, according to MarketScreener.

What does the pipeline mean?

The project mix extends Aedifica's healthcare real estate footprint beyond traditional care homes. The Limerick development is the company's first investment in a new healthcare real estate subsegment, while the 2028 completion schedule gives investors a dated view of future asset additions.

Three milestones in 2026

On June 30, 2026, Aedifica completed the acquisition of the remaining 20.43 percent stake in Cofinimmo, as reported by MarketScreener. On October 12, 2026, the Irish projects represented EUR 105.00 million of investment. On October 16, 2026, MarketScreener reported Moody's first-time rating for Aedifica after the Cofinimmo purchase.

Dates for the next update

Aedifica's next interim statement is scheduled for November 18, 2026, at 5:40 p.m. CET. The company also lists Finance Avenue 2026 for November 28, 2026, according to its investor calendar.

Stock price and investor view

Aedifica stock was trading at EUR 62.58 at Lang & Schwarz on October 20, 2026, at 10:42 a.m. CEST. The dated price places the Irish development program alongside a clear near-term reporting date, while the construction timetable extends into 2028.

The further course of trading is shown by the continuously updated real-time quote of Aedifica stock.

Aedifica stock facts

  • Company: Aedifica S.A.
  • ISIN: BE0003851681
  • Ticker: AED
  • Primary exchange: Euronext Brussels
  • Price Lang & Schwarz (as of October 20, 2026, 10:42 a.m. CEST): EUR 62.58
  • Market capitalization: USD 6.9 billion (as of October 16, 2026)
  • Sector / Industry: Real Estate / Healthcare Facilities
  • Index membership: BEL 20

Market context: Market report Euro Stoxx 50.

More news and analyses on Aedifica stock

Disclaimer...
en | BE0003851681 | AEDIFICA | boerse | 70371109 | bgmi